GRI Bio (GRI) Capital Expenditures (2020 - 2022)
GRI Bio's Capital Expenditures came in at $3,000 for FY2025.
Powered by 
Analysis
GRI Bio (GRI) Capital Expenditures (2020 - 2022) Analysis & Trends
Going back to FY2020, GRI Bio's Capital Expenditures data covers 4 years.
- Capital Expenditures carries a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- Per Business Quant, earlier years put Capital Expenditures at $8,000 in FY2023 (+166.7%) and $3,000 in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.40 Bn | 1,140.99 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 642.90 Bn | 561.42 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 375.88 Bn | 330.26 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.81 Bn | 266.80 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 268.58 Bn | 242.27 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 242.38 Bn | 197.78 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 533.00 Mn |
| 10 | GRI Bio | 2.56 Mn | -31.72 Mn | - | - |
API Access
GRI Bio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();